Preferred Label : Tardive Dyskinesia;

MeSH definition : Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).;

MeSH synonym : Dyskinesia, Tardive; Dyskinesias, Tardive; Tardive Dyskinesias; Tardive Dystonia; Dystonia, Tardive; Dystonias, Tardive; Tardive Dystonias;

Wikipedia link : https://en.wikipedia.org/wiki/Tardive dyskinesia;

Details


Main resources

You can consult :

Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).

http://www.cochrane.org/fr/CD000204
2012
false
France
United Kingdom
French
french abstract
french abstract
french abstract
french abstract
review of literature
review of literature
review of literature
review of literature
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
treatment outcome
treatment outcome
treatment outcome
treatment outcome
cholinergic antagonists
cholinergic antagonists
cholinergic antagonists
cholinergic antagonists
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia

---
http://www.cochrane.org/fr/CD000203
2012
false
France
United Kingdom
French
french abstract
french abstract
french abstract
french abstract
meta-analysis
meta-analysis
meta-analysis
meta-analysis
GABA agonists
GABA agonists
GABA agonists
GABA agonists
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
treatment outcome
treatment outcome
treatment outcome
treatment outcome
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia

---
http://www.cochrane.org/fr/CD000208
2011
false
false
false
France
United Kingdom
treatment outcome
treatment outcome
treatment outcome
treatment outcome
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
review of literature
review of literature
review of literature
review of literature
french abstract
french abstract
french abstract
french abstract
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced

---
http://www.cochrane.org/fr/CD000209
2011
false
true
false
France
United Kingdom
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
dyskinesia, drug-induced
treatment outcome
treatment outcome
treatment outcome
treatment outcome
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
Tardive Dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
neuroleptic-induced tardive dyskinesia
review of literature
review of literature
review of literature
review of literature
french abstract
french abstract
french abstract
french abstract
antipsychotic agents
antipsychotic agents
antipsychotic agents
antipsychotic agents
vitamin E
vitamin E
vitamin E
vitamin E

---
Nous contacter.
11/12/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.